|
|
|
|
|
 |
Moulay Alaoui-Jamali Scientific Advisor
Dr. Moulay Alaoui-Jamali, Professor of Oncology and Medicine, Faculty of Medicine, McGill University. As a recognized authority in cancer research, Dr. Alaoui-Jamali has been engaged in basic and translational cancer research for many years. He has expertise in tumor biology, cancer pharmacology, experimental therapeutics, and cancer target discovery. He has published extensively in these areas and has been serving on several scientific panels and research committees, including the CIHR, NCIC, and the College of Reviewers for the Canada Research Chair Program. He has held numerous grants and awards, including from the NCIC, CIHR, FRSQ, US Army Research Program, and Canada Foundation for Innovation. Dr. Alaoui-Jamali received his Ph.D. in Molecular Cancer Pharmacology from the National Cancer Institute and René-Déscartes University and Faculty of Medicine Lariboisière-Saint-Louis (Sorbonne), Paris, France in 1986. He completed his post-doctoral training at the Cancer Centre, Roswell Park Memorial Institute, New York University in Buffalo, USA.
|
|
 |
|
::: Copyright © 1995 - 2008 Welichem Biotech Inc. All Rights Resevered :::
|
 |
|